Cargando…

Deficiency of CREB and over expression of miR-183 in juvenile myelomonocytic leukemia

Detalles Bibliográficos
Autores principales:	Liu, Y L, Lensing, S Y, Yan, Y, Cooper, T M, Loh, M L, Emanuel, P D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715750/ https://www.ncbi.nlm.nih.gov/pubmed/23417028 http://dx.doi.org/10.1038/leu.2013.49

Ejemplares similares

The Genomic Landscape of Juvenile Myelomonocytic Leukemia
por: Stieglitz, Elliot, et al.
Publicado: (2015)

Novel splicing-factor mutations in juvenile myelomonocytic leukemia
por: Takita, J, et al.
Publicado: (2012)

Current Treatment of Juvenile Myelomonocytic Leukemia
por: Mayerhofer, Christina, et al.
Publicado: (2021)

Molecular and phenotypic diversity of CBLmutated juvenile myelomonocytic leukemia
por: Hecht, Anna, et al.
Publicado: (2020)

Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia
por: Liu, Xiaoling, et al.
Publicado: (2012)

Genomic and Epigenomic Landscape of Juvenile Myelomonocytic Leukemia
por: Fiñana, Claudia, et al.
Publicado: (2022)

Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia
por: Stieglitz, Elliot, et al.
Publicado: (2017)

Juvenile Myelomonocytic Leukemia: Molecular Pathogenesis Informs Current Approaches to Therapy and Hematopoietic Cell Transplantation
por: Dvorak, Christopher C., et al.
Publicado: (2014)

Use of Rapamycin in a Patient With Juvenile Myelomonocytic Leukemia: A Case Report
por: Upadhyay, Shivani Y., et al.
Publicado: (2017)

Juvenile myelomonocytic leukemia in the molecular era: a clinician’s guide to diagnosis, risk stratification, and treatment
por: Wintering, Astrid, et al.
Publicado: (2021)

Exploring the genetic and epigenetic origins of juvenile myelomonocytic leukemia using newborn screening samples
por: Behnert, Astrid, et al.
Publicado: (2021)

P1072: NATURAL HISTORY OF JUVENILE MYELOMONOCYTIC LEUKEMIA
por: Yang, W., et al.
Publicado: (2022)

Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia
por: Kitazawa, Hironobu, et al.
Publicado: (2021)

Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia
por: Niemeyer, Charlotte M., et al.
Publicado: (2010)

Single-Center Experience With Epigenetic Treatment for Juvenile Myelomonocytic Leukemia
por: Marcu, Andra, et al.
Publicado: (2020)

Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia
por: Louka, Eleni, et al.
Publicado: (2021)

Clinical and molecular features of CBL-mutated juvenile myelomonocytic leukemia
por: Yoshida, Taro, et al.
Publicado: (2023)

CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia
por: Fluhr, Silvia, et al.
Publicado: (2016)

Gene module analysis of juvenile myelomonocytic leukemia and screening of anticancer drugs
por: Zhao, Wencheng, et al.
Publicado: (2018)

Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay
por: Stieglitz, Elliot, et al.
Publicado: (2023)

Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia
por: Hofmans, Mattias, et al.
Publicado: (2021)

Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL
por: Gagne, Alyssa L., et al.
Publicado: (2018)

MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment
por: Leoncini, Pier Paolo, et al.
Publicado: (2016)

RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
por: Lipka, Daniel B., et al.
Publicado: (2017)

Mutation-Specific Signaling Profiles and Kinase Inhibitor Sensitivities of Juvenile Myelomonocytic Leukemia Revealed by Induced Pluripotent Stem Cells
por: Tasian, Sarah K, et al.
Publicado: (2018)

Management of Two Juvenile Myelomonocytic Leukemia Patients According to Clinical and Genetic Features
por: Tüfekçi, Özlem, et al.
Publicado: (2015)

Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia
por: Sakaguchi, Hirotoshi, et al.
Publicado: (2015)

Juvenile Myelomonocytic Leukemia in Turkey: A Retrospective Analysis of Sixty-five Patients
por: Tüfekçi, Özlem, et al.
Publicado: (2018)

Parvovirus B19 Infection Mimicking Juvenile Myelomonocytic Leukemia in an Immunocompetent Child
por: Mathew, Aji, et al.
Publicado: (2020)

P985: CLL-1 IS AN ADOPTIVE IMMUNOTHERAPY TARGET IN JUVENILE MYELOMONOCYTIC LEUKEMIA
por: Huebner, Juwita, et al.
Publicado: (2023)

MiR-582-5p/miR-590-5p targeted CREB1/CREB5–NF-κB signaling and caused opioid-induced immunosuppression in human monocytes
por: Long, X, et al.
Publicado: (2016)

Allogeneic bone marrow transplantation for juvenile myelomonocytic leukemia: a single center experience of 23 patients
por: Korthof, E T, et al.
Publicado: (2005)

CircRNAs Dysregulated in Juvenile Myelomonocytic Leukemia: CircMCTP1 Stands Out
por: Dal Molin, Anna, et al.
Publicado: (2021)

Prolonged Pediatric Extracorporeal Membrane Oxygenation Support with Cardiopulmonary Failure in Juvenile Myelomonocytic Leukemia
por: Bartkevics, Maris, et al.
Publicado: (2020)

Case Report: Juvenile Myelomonocytic Leukemia Underlying Ornithine Transcarbamylase Deficiency Safely Treated Using Hematopoietic Stem Cell Transplantation
por: Eguchi, Hiroi, et al.
Publicado: (2022)

Leukemia cutis in a child with juvenile myelomonocytic leukemia presenting with Sweet syndrome–like lesions and a history of multiple juvenile xanthogranulomas
por: Quek, Chrystie Wan Ning, et al.
Publicado: (2020)

Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia
por: Hasegawa, D, et al.
Publicado: (2013)

Cytosine Arabinoside and Mitoxantrone Followed by Second Allogeneic Transplant for the Treatment of Children With Refractory Juvenile Myelomonocytic Leukemia
por: Patel, Sachit A., et al.
Publicado: (2014)

The miR-183∼96∼182 cluster promotes tumorigenesis in a mouse model of medulloblastoma
por: Zhang, Zengdi, et al.
Publicado: (2013)

Coexistence of Chronic Myelomonocytic Leukemia and Ulcerative Colitis With Rapid Progression to Acute Myelomonocytic Leukemia: A Case Report
por: Pelkey, Lauren J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_377ftvb95a32nnrb1dkicbdtpc